ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Recurrence"

  • 2015 American Transplant Congress

    Risk of Post Liver Transplant (LT) Hepatocellular Carcinoma (HCC) Recurrence Is 2-Fold Higher in Women Compared to Men With AFP Levels at LT Between 101-500

    M. Sarkar,1 J. Dodge,2 F. Yao,1 J. Roberts,2 N. Terrault,1 N. Mehta.1

    1Medicine, University of California, San Francisco, San Francisco; 2Surgery, University of California, San Francisco, San Francisco.

    Gender differences in HCC incidence are known, with men at greater risk than women. Pre transplant AFP levels strongly predict post LT HCC recurrence, though…
  • 2015 American Transplant Congress

    Liver Transplantation for Primary Liver Malignancies Vs. Neuroendocrine Metastases: Analysis of the UNOS Dataset

    V. Vilchez,1 M. Shah,1 M. Daily,1 S. Krohmer,2 D. Davenport,1 E. Maynard,1 R. Gedaly.1

    1Department of Surgery - Transplant Section, University of Kentucky, Lexington, KY; 2Department of Radiology, University of Kentucky, Lexington, KY.

    Objective: To determine outcome in patients undergoing LT for NETs, and compared them with outcomes in patients with primary liver malignancies such as Hepatocellular Carcinoma…
  • 2015 American Transplant Congress

    Focal Segmental Glomerulosclerosis Recurrence in Renal Transplant Recipients Treated With Belatacept

    W. Kitchens,1 A. Farris,2 S. Pastan,1 T. Pearson,1 C. Larsen,1 A. Adams.1

    1Emory Transplant Center, Atlanta, GA; 2Department of Pathology, Emory University Hospital, Atlanta, GA.

    Introduction: Focal segmental glomerulosclerosis (FSGS) is a cause of end-stage renal failure that frequently recurs following renal transplant, often leading to early allograft loss. A…
  • 2015 American Transplant Congress

    The use of Donation After Cardiac Death Liver Allografts does not increase Recurrence of Hepatocellular Carcinoma

    K. Croome, D. Lee, J. Burns, J. Nguyen, D. Perry, D. Harnois, C. Taner.

    Transplant, Mayo Clinic, Jacksonville, FL.

    Background: Previous studies examining the Scientific Registry of Transplant Recipients (SRTR) database for liver transplantation (LT) have demonstrated inferior survival for hepatocellular carcinoma (HCC) recipients…
  • 2015 American Transplant Congress

    Pretransplant Elevated Plasma Fibrinogen Level Is Associated With Tumor Recurrence and Poor Prognosis in Hepatocellular Carcinoma Patients After Liver Transplantation

    G.-Y. Wang, Y. Yang, H. Li, S.-H. Yi, G.-H. Chen.

    Department of Hepatic Surgery and Liver Transplant Center, Third Affiliated Hospital, Sun Yat-sen University, Organ Transplantation Institution of Sun Yat-sen University, Guangzhou, China.

    Background and Objective: Elevated plasma fibrinogen (FBG) level is associated with tumor progression and poor patient outcomes in several cancers. The aim of this study…
  • 2015 American Transplant Congress

    Associations Between Sirolimus Use and Outcomes After Liver Transplant for Hepatocellular Carcinoma

    E. Yanik,1 S. Chinnakotla,2 A. Israni,2,3 J. Snyder,2,3 S. Gustafson,3 E. Engels.1

    1Natl. Cancer Inst., Bethesda, MD; 2U. of Minnesota, Minneapolis, MN; 3Sci. Reg. of Transplant Recipients, Minneapolis, MN.

    A growing fraction of U.S. liver transplants are being done for the indication of hepatocellular carcinoma (HCC). HCC recurrence after transplant remains a major concern…
  • 2015 American Transplant Congress

    Predictors of Time to Recurrence and Mortality Associated With Recurrent Hepatocellular Carcinoma After Liver Transplantation

    A. Bodzin, D. Reino, K. Lunsford, M. Harlander-Locke, D. Markovich, A. Zarrinpar, F. Kaldas, D. Farmer, R. Busuttil, V. Agopian.

    Transplantation, UCLA, Los Angeles, CA.

    Background: While recurrent hepatocellular carcinoma (HCC) after liver transplantation (LT) portends a poor prognosis, adjuvant therapy may prolong survival. We sought to identify factors that…
  • 2015 American Transplant Congress

    Recurrence of Hepatocellular Carcinoma After Transarterial Chemoembolization (TACE) Alone and TACE in Combination With Other Treatment Modalities

    J. Balogh, A. Islam, A. Saharia, H. Monsour, S. Gordon Burroughs, M. Weiner, A. Gaber, R. Ghobrial.

    General Surgery, Houston Methodist Hospital, Houston, TX.

    AIM:Treatment of hepatocellular carcinoma (HCC) with transarterial chemoembolization (TACE) can help downstage tumors prior to orthotopic liver transplantation (OLT); however, there is a risk of…
  • 2015 American Transplant Congress

    Glomerular Disease (GD) After Kidney Transplant (KTx): Etiologies, Risk Factors and Consequences

    F. Cosio,1 A. Grupper,1 E. Lorenz,1 M. Alexander,2 L. Cornell.2

    1Nephrology, Mayo Clinic, Rochester, MN; 2Pathology, Mayo Clinic, Rochester, MN.

    Introduction. Recipients who develop KTx GD may have reduced function and higher risk of graft loss. Using protocol and clinical biopsies we sought to determine…
  • 2015 American Transplant Congress

    Early Relapse of Atypical HUS Following ABO Incompatible Living Related Paediatric Renal Re-Transplant Successfully Treated With Eculizumab

    J. Stojanovic,1 A. Adamusiak,2 N. Sebire,3 S. Marks,1 N. Mamode.2

    1Department of Paediatric Nephrology, Great Ormond Street Hospital NHS Foundation Trust, London, United Kingdom; 2Department of Transplantation, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom; 3Department of Histopathology, Great Ormond Street Hospital NHS Foundation Trust, London, United Kingdom.

    Background. The female patient presented at 3 years of age with clinical features suggestive of aHUS confirmed genetically as complement factor I mutation (heterozygous for…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences